Figure 1From: Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki diseaseResistin, S100A12 and soluble receptor for advanced glycation end products (sRAGE) levels at different stages of Kawasaki disease (KD) in patients treated with intravenous immunoglobulin (IVIG). KD-I, acute stage; KD-II, afebrile stage; KD-III, subacute stage.Back to article page